Hyperaldosteronism: Difference between revisions
| Line 32: | Line 32: | ||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
* Essential hypertension | |||
* | |||
* Cushing’s syndrome | |||
* | |||
* Pheochromocytoma | |||
* | |||
* Renal artery stenosis | |||
* | |||
* Diuretic or laxative use | |||
* | |||
* Liddle syndrome | |||
* | |||
* Bartter/Gitelman syndromes | |||
* | |||
* Chronic licorice ingestion | |||
==Evaluation== | ==Evaluation== | ||
Revision as of 23:43, 5 May 2025
Background
Hyperaldosteronism refers to a condition of excess aldosterone secretion, typically leading to sodium retention, potassium excretion, and metabolic alkalosis. It is categorized into:
- Primary hyperaldosteronism (Conn syndrome) – autonomous overproduction of aldosterone, most commonly from an adrenal adenoma or bilateral adrenal hyperplasia.
- Secondary hyperaldosteronism – due to increased renin from conditions like renal artery stenosis, heart failure, or cirrhosis.
Primary hyperaldosteronism is an important and potentially reversible cause of secondary hypertension, accounting for 5–10% of hypertensive cases and up to 20% of treatment-resistant hypertension. It is often underdiagnosed in emergency settings.
Clinical Features
- Hypertension (often severe or resistant)
- Hypokalemia, which may manifest as:
- Weakness
- Fatigue
- Muscle cramps
- Constipation
- Paresthesia
- Polyuria and polydipsia
- Metabolic alkalosis (less commonly symptomatic)
- Headache or nonspecific complaints
- Asymptomatic in some patients
Differential Diagnosis
- Essential hypertension
- Cushing’s syndrome
- Pheochromocytoma
- Renal artery stenosis
- Diuretic or laxative use
- Liddle syndrome
- Bartter/Gitelman syndromes
- Chronic licorice ingestion
